Compare AMPH & EVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | EVLV |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 988.3M |
| IPO Year | 2014 | N/A |
| Metric | AMPH | EVLV |
|---|---|---|
| Price | $27.12 | $6.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | ★ $31.00 | $9.13 |
| AVG Volume (30 Days) | 389.3K | ★ 2.6M |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.27 | N/A |
| Revenue | ★ $723,305,000.00 | $136,501,000.00 |
| Revenue This Year | $1.35 | $41.14 |
| Revenue Next Year | $5.10 | $14.60 |
| P/E Ratio | $11.87 | ★ N/A |
| Revenue Growth | N/A | ★ 43.16 |
| 52 Week Low | $20.39 | $2.64 |
| 52 Week High | $39.56 | $8.91 |
| Indicator | AMPH | EVLV |
|---|---|---|
| Relative Strength Index (RSI) | 55.26 | 46.40 |
| Support Level | $26.26 | $6.54 |
| Resistance Level | $27.44 | $7.48 |
| Average True Range (ATR) | 0.82 | 0.27 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 83.33 | 15.82 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.